146 related articles for article (PubMed ID: 34546155)
1. Noninvasive Estimation of Hepatic Steatosis by Controlled Attenuation Parameter in Living Donor Liver Transplant.
Eshraghian A; Fattahi MR; Mansourian M; Nikeghbalian S; Dehghani SM; Taghavi A; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
Exp Clin Transplant; 2022 Jul; 20(7):674-679. PubMed ID: 34546155
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.
Hong YM; Yoon KT; Cho M; Chu CW; Rhu JH; Yang KH; Lee JW
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):805-810. PubMed ID: 28379854
[TBL] [Abstract][Full Text] [Related]
3. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.
Kim JM; Ha SY; Joh JW; Sinn DH; Jeong WK; Choi GS; Gwak GY; Kwon CHD; Kim YK; Paik YH; Lee JH; Lee WJ; Lee SK; Park CK
Medicine (Baltimore); 2016 Feb; 95(7):e2718. PubMed ID: 26886612
[TBL] [Abstract][Full Text] [Related]
4. Vibration Controlled Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation.
Palte E; Duong JK; Remotti H; Burt J; Makkar J; Samstein B; Verna EC; Marratta D; Emond JC; Fox AN
Transplantation; 2023 Sep; 107(9):1991-1998. PubMed ID: 36959124
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
Jang JK; Kim SY; Yoo IW; Cho YB; Kang HJ; Lee DH
Eur Radiol; 2022 Mar; 32(3):2070-2077. PubMed ID: 34549325
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Computed Tomography Volumetry for Noninvasive Detection of Hepatic Steatosis and Steatohepatitis in Living Liver Donors.
Eshraghian A; Rasekhi A; Nikeghbalian S; Muhammad S; Kazemi K; Jalaeian H; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
Exp Clin Transplant; 2022 Apr; 20(4):388-394. PubMed ID: 31266439
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Togashi J; Ohki T; Yoshida H; Omata M; Makuuchi M; Kokudo N
Transplantation; 2009 Aug; 88(4):575-81. PubMed ID: 19696642
[TBL] [Abstract][Full Text] [Related]
8. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
9. Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter.
Yen YH; Kuo FY; Lin CC; Chen CL; Chang KC; Tsai MC; Hu TH
Transplant Proc; 2018 Dec; 50(10):3533-3538. PubMed ID: 30577232
[TBL] [Abstract][Full Text] [Related]
10. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Chan WK; Nik Mustapha NR; Mahadeva S
J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
[TBL] [Abstract][Full Text] [Related]
11. Characterization of hepatic steatosis using controlled attenuation parameter and MRI-derived proton density fat fraction in living donor liver transplantation.
Zhuang RH; Weinstock AK; Ganesh S; Behari J; Malik SM; Bataller R; Furlan A; Hughes CB; Humar A; Duarte-Rojo A
Clin Transplant; 2022 Nov; 36(11):e14786. PubMed ID: 35993599
[TBL] [Abstract][Full Text] [Related]
12. Discordance in steatosis classification between liver biopsy and transient elastography for high controlled attenuation parameter (CAP) values.
Galaski J; Schulz L; Krause J; Lohse AW
Z Gastroenterol; 2018 Jan; 56(1):36-42. PubMed ID: 29316576
[TBL] [Abstract][Full Text] [Related]
13. Is Unenhanced Computed Tomography Reliable in the Assessment of Macrovesicular Steatosis in Living Liver Donors?
Haberal KM; Turnaoğlu H; Haberal Reyhan AN
Exp Clin Transplant; 2019 Dec; 17(6):749-752. PubMed ID: 31666000
[TBL] [Abstract][Full Text] [Related]
14. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
15. Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.
Broering D; Shawkat M; Albenmousa A; Abaalkhail F; Alabbad S; Al-Hamoudi W; Alghamdi S; Alqahthani S; Jaafari A; Troisi R; Bzeizi K
PLoS One; 2021; 16(5):e0251487. PubMed ID: 33984017
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive evaluation of graft steatosis in living donor liver transplantation.
Iwasaki M; Takada Y; Hayashi M; Minamiguchi S; Haga H; Maetani Y; Fujii K; Kiuchi T; Tanaka K
Transplantation; 2004 Nov; 78(10):1501-5. PubMed ID: 15599315
[TBL] [Abstract][Full Text] [Related]
17. Value of the ultrasound attenuation index for noninvasive quantitative estimation of hepatic steatosis.
Kwon HJ; Kim KW; Lee SJ; Kim SY; Lee JS; Kim HJ; Song GW; Kim SA; Yu ES; Lee J; Hwang S; Lee SG
J Ultrasound Med; 2013 Feb; 32(2):229-35. PubMed ID: 23341377
[TBL] [Abstract][Full Text] [Related]
18. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.
Lee SW; Park SH; Kim KW; Choi EK; Shin YM; Kim PN; Lee KH; Yu ES; Hwang S; Lee SG
Radiology; 2007 Aug; 244(2):479-85. PubMed ID: 17641368
[TBL] [Abstract][Full Text] [Related]
19. Comparison of CT methods for determining graft steatosis in living donor liver transplantation.
Şeker M; Erol C; Sevmiş Ş; Saka B; Durur Karakaya A
Abdom Radiol (NY); 2019 Jul; 44(7):2418-2429. PubMed ID: 30937504
[TBL] [Abstract][Full Text] [Related]
20. Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy.
Yilmaz Y; Yesil A; Gerin F; Ergelen R; Akin H; Celikel ÇA; Imeryuz N
Scand J Gastroenterol; 2014 May; 49(5):611-6. PubMed ID: 24611771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
